AstraZeneca PLC — Director's Dealing 2016

Feb 26, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2818Q

AstraZeneca PLC

26 February 2016

Transaction by Person Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

On 25 February 2016, the interest of Mr Pascal Soriot, a person discharging managerial responsibilities, in the ordinary shares of AstraZeneca PLC changed as detailed below.

The change in interest relates to the previously announced award of shares made in February 2013 under the AstraZeneca Deferred Bonus Plan. Under the terms of the award, Mr Soriot has now become beneficially entitled to the shares.

After sufficient shares were withheld to satisfy certain tax obligations arising on the vesting, Mr Soriot has become beneficially entitled to and has received 3,039 shares into a personal brokerage account.

For tax purposes, the fair market value of the shares at vest was 4086.5 pence per share being the closing price of AstraZeneca ordinary shares on the last trading day preceding the vesting day.

A C N Kemp

Company Secretary

26 February 2016

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSUNOKRNRAUURR